Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions
Language: en
Bundle bundle-drug-product-compatibility-pq-ex1 of type collection
Entry 1 - fullUrl = urn:uuid:1e1e1e1e-1e1e-1e1e-1e1e-1e1e1e1e1e1e
Resource MedicinalProductDefinition:
Language: en
identifier:
http://example.org/identifiers/product/PROD-12345combinedPharmaceuticalDoseForm: Tablet
route: Oral use
Names
ProductName Type Stelbatolol 10mg Tablets Invented Name
Entry 2 - fullUrl = urn:uuid:2e2e2e2e-2e2e-2e2e-2e2e-2e2e2e2e2e2e
Resource Medication:
Language: en
code:
batch
Medication Manufacturing Batch
url
manufacturingDatevalue: 2020-06
url
batchQuantityvalue: 100100 tablets
url
batchUtilizationvalue: Production
url
assignedManufacturervalue: Organization AAA Molybdenum Products, Inc.
closureSystemDescription: 100 cc HDPE Bottle 2 g desiccant
url
containerExtension - Batch Release Date PQ: 2019-09-08
Extension - Batch Designation PQ: Maximum
Extension - Batch Number of Vials PQ: 3
Extension - Batch Substance Batch PQ: Substance
Extension - Packaging Date PQ: 2020-08
Extension - Packaging Site PQ: Organization AAA Molybdenum Products, Inc.
Extension - Actual Yield PQ: 4.81 kg
Extension - Actual Yield Unfiltered PQ: 4.91 kg
Extension Target Fill Weight PQ: 30 g
lotNumber: 33445
Entry 3 - fullUrl = urn:uuid:3e3e3e3e-3e3e-3e3e-3e3e-3e3e3e3e3e3e
Resource PlanDefinition:
Metadata Title Stability Monitoring Program Subject Type MedicinalProductDefinition: identifier = http://example.org/identifiers/product#PROD-12345; combinedPharmaceuticalDoseForm = Tablet; route = Oral use Description Narrative description of Stability Study
Type Stability Study Protocol PlanDefinition Action Title Stability Test Protocol for Long-term and Accelerated Storage of Stelbat Tablets, 20 mg PlanDefinition Sub-Action (Parent Action Title: Stability Test Protocol for Long-term and Accelerated Storage of Stelbat Tablets, 20 mg) Title Long-Term Description 25°C/60% RH
PlanDefinition Sub-Action (Parent Action Title: Long-Term) Title Initial Timing Once PlanDefinition Sub-Action (Parent Action Title: Initial) Title XYZ Definition http://example-server.com/fhir/ActivityDefinition/4bfe1ee8-91ed-5c1b-3045-c749bb9d1d90Generated using version 0.5.4 of the sample-content-ig Liquid templates
Entry 4 - fullUrl = urn:uuid:4e4e4e4e-4e4e-4e4e-4e4e-4e4e4e4e4e4e
Resource ObservationDefinition:
Language: en
status: Active
code: Assay
method: Assay by UHPLC
Entry 5 - fullUrl = urn:uuid:5e5e5e5e-5e5e-5e5e-5e5e-5e5e5e5e5e5e
Resource DiagnosticReport:
Language: en
Profile: DiagnosticReport - Analysis Drug PQ
Stability Study Report - 18 months
When For 2020-12 Performer Organization AAA Molybdenum Products, Inc. Identifier https://eudract.europa.eu/example/identifier/ABC1234Report Details
Code Value Flags When For Test Components - Long-term 25C etc - Initial (XYZ) Final 2023-01-01 12:00:00+0000 The samples have been assessed for initial period; no shelf life determined.
Entry 6 - fullUrl = urn:uuid:6e6e6e6e-6e6e-6e6e-6e6e-6e6e6e6e6e6e
Resource Observation:
Language: en
Profile: Observation - Test Result Drug PQ
Triggered by: Example of ActivityDefinition - Test for test set: Long-term - 25°C/60% RH - XYZ.
status: Final
code: Test Components - Long-term 25C etc - Initial (XYZ)
subject: Medication
effective: 2023-01-01 12:00:00+0000
performer: Organization AAA Molybdenum Products, Inc.
specimen: Specimen
hasMember:
Entry 7 - fullUrl = urn:uuid:7e7e7e7e-7e7e-7e7e-7e7e-7e7e7e7e7e7e
Resource Organization:
Language: en
Profile: Organization - Drug PQ
identifier: FDA Establishment Identifier/3003040516
active: true
type: Drug Substance Manufacture
name: AAA Molybdenum Products, Inc.
Contacts
Address 7233 W 116th Pl Ste C Broomfield Colorado 80020 USA